C

Chabiotech Co Ltd
KOSDAQ:085660

Watchlist Manager
Chabiotech Co Ltd
KOSDAQ:085660
Watchlist
Price: 10 740 KRW -27.73%
Market Cap: 604.8B KRW
Have any thoughts about
Chabiotech Co Ltd?
Write Note

Chabiotech Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Chabiotech Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
C
Chabiotech Co Ltd
KOSDAQ:085660
Accounts Receivables
â‚©123.3B
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
10%
No Stocks Found

Chabiotech Co Ltd
Glance View

Market Cap
604.8B KRW
Industry
Health Care

Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-27. is a Korea-based company mainly engaged in the bio business. Along with its subsidiaries, the Company operates its business through two segments: bio segment and optical segment. Its bio segment engages in the provision of medical services; development of stem cells and cell therapy products; production of cosmetics and cosmetic raw materials; distribution of medical devices and others, as well as cord blood storage, health care services and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phone cameras.

Intrinsic Value
9 965.82 KRW
Overvaluation 7%
Intrinsic Value
Price
C

See Also

What is Chabiotech Co Ltd's Accounts Receivables?
Accounts Receivables
123.3B KRW

Based on the financial report for Sep 30, 2024, Chabiotech Co Ltd's Accounts Receivables amounts to 123.3B KRW.

What is Chabiotech Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
10%

Over the last year, the Accounts Receivables growth was 22%. The average annual Accounts Receivables growth rates for Chabiotech Co Ltd have been 13% over the past three years , 10% over the past five years , and 10% over the past ten years .

Back to Top